The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Carcinoma, Endometrioid

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Carcinoma, Endometrioid


High impact information on Carcinoma, Endometrioid


Chemical compound and disease context of Carcinoma, Endometrioid


Biological context of Carcinoma, Endometrioid


Anatomical context of Carcinoma, Endometrioid


Gene context of Carcinoma, Endometrioid


Analytical, diagnostic and therapeutic context of Carcinoma, Endometrioid


  1. Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas. Moreno-Bueno, G., Sánchez-Estévez, C., Cassia, R., Rodríguez-Perales, S., Díaz-Uriarte, R., Domínguez, O., Hardisson, D., Andujar, M., Prat, J., Matias-Guiu, X., Cigudosa, J.C., Palacios, J. Cancer Res. (2003) [Pubmed]
  2. PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Levine, R.L., Cargile, C.B., Blazes, M.S., van Rees, B., Kurman, R.J., Ellenson, L.H. Cancer Res. (1998) [Pubmed]
  3. beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome. Gamallo, C., Palacios, J., Moreno, G., Calvo de Mora, J., Suárez, A., Armas, A. Am. J. Pathol. (1999) [Pubmed]
  4. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer. Santin, A.D., Diamandis, E.P., Bellone, S., Soosaipillai, A., Cane, S., Palmieri, M., Burnett, A., Roman, J.J., Pecorelli, S. Clin. Cancer Res. (2005) [Pubmed]
  5. Cancer-testis antigen expression in uterine malignancies with an emphasis on carcinosarcomas and papillary serous carcinomas. Resnick, M.B., Sabo, E., Kondratev, S., Kerner, H., Spagnoli, G.C., Yakirevich, E. Int. J. Cancer (2002) [Pubmed]
  6. Noncontraceptive estrogen use and the occurrence of ovarian cancer. Weiss, N.S., Lyon, J.L., Krishnamurthy, S., Dietert, S.E., Liff, J.M., Daling, J.R. J. Natl. Cancer Inst. (1982) [Pubmed]
  7. FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development. Chamorro, M.N., Schwartz, D.R., Vonica, A., Brivanlou, A.H., Cho, K.R., Varmus, H.E. EMBO J. (2005) [Pubmed]
  8. Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. Hendrix, N.D., Wu, R., Kuick, R., Schwartz, D.R., Fearon, E.R., Cho, K.R. Cancer Res. (2006) [Pubmed]
  9. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Sato, N., Tsunoda, H., Nishida, M., Morishita, Y., Takimoto, Y., Kubo, T., Noguchi, M. Cancer Res. (2000) [Pubmed]
  10. CA54/61 as a marker for epithelial ovarian cancer. Nozawa, S., Aoki, D., Yajima, M., Tsukazaki, K., Kobayashi, T., Kimura, E., Terashima, Y., Inaba, N., Takamizawa, H., Negishi, Y. Cancer Res. (1992) [Pubmed]
  11. Ovarian endometrioid carcinomas resembling sex cord-stromal tumors. A clinicopathological analysis of 13 cases. Young, R.H., Prat, J., Scully, R.E. Am. J. Surg. Pathol. (1982) [Pubmed]
  12. Morules with biotin-containing optically clear nuclei in colonic tubular adenoma. Sasaki, A., Yokoyama, S., Arita, T., Inomata, M., Kashima, K., Nakayama, I. Am. J. Surg. Pathol. (1999) [Pubmed]
  13. Ovarian endometrioid adenocarcinoma arising from an endometriotic cyst in a postmenopausal woman under tamoxifen therapy for breast cancer: a case report. Okugawa, K., Hirakawa, T., Ogawa, S., Kaku, T., Nakano, H. Gynecol. Oncol. (2002) [Pubmed]
  14. Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53. Horiuchi, A., Osada, R., Nakayama, K., Toki, T., Nikaido, T., Fujii, S. Gynecol. Oncol. (1998) [Pubmed]
  15. Disseminated granulomatous disease (BCGosis) following chemoimmunotherapy for ovarian carcinoma. Kelleher, M.B., Christopherson, W.A., Macpherson, T.A. Gynecol. Oncol. (1988) [Pubmed]
  16. Histologic type, organ of origin, and Wnt pathway status: effect on gene expression in ovarian and uterine carcinomas. Shedden, K.A., Kshirsagar, M.P., Schwartz, D.R., Wu, R., Yu, H., Misek, D.E., Hanash, S., Katabuchi, H., Ellenson, L.H., Fearon, E.R., Cho, K.R. Clin. Cancer Res. (2005) [Pubmed]
  17. Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus - correlation with proliferation and clinicopathological parameters. Watanabe, J., Sato, H., Kanai, T., Kamata, Y., Jobo, T., Hata, H., Fujisawa, T., Ohno, E., Kameya, T., Kuramoto, H. Br. J. Cancer (2002) [Pubmed]
  18. Insulin-like growth factor-I receptor and PTEN protein expression in endometrial carcinoma. Correlation with bax and bcl-2 expression, microsatellite instability status, and outcome. Peiró, G., Lohse, P., Mayr, D., Diebold, J. Am. J. Clin. Pathol. (2003) [Pubmed]
  19. Loss of expression and nuclear/cytoplasmic localization of the FOXP1 forkhead transcription factor are common events in early endometrial cancer: relationship with estrogen receptors and HIF-1alpha expression. Giatromanolaki, A., Koukourakis, M.I., Sivridis, E., Gatter, K.C., Harris, A.L., Banham, A.H. Mod. Pathol. (2006) [Pubmed]
  20. Possible precursor of HNPCC-related endometrioid carcinoma of the uterus. Zamecnik, M. Am. J. Surg. Pathol. (2004) [Pubmed]
  21. Peritoneal keratin granulomas with carcinomas of endometrium and ovary and atypical polypoid adenomyoma of endometrium. A clinicopathological analysis of 22 cases. Kim, K.R., Scully, R.E. Am. J. Surg. Pathol. (1990) [Pubmed]
  22. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers. Xiong, Y., Dowdy, S.C., Xue, A., Shujuan, J., Eberhardt, N.L., Podratz, K.C., Jiang, S.W. Gynecol. Oncol. (2005) [Pubmed]
  23. Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance. Murray, S.K., Young, R.H., Scully, R.E. Int. J. Gynecol. Pathol. (2003) [Pubmed]
  24. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Wu, R., Zhai, Y., Fearon, E.R., Cho, K.R. Cancer Res. (2001) [Pubmed]
  25. High frequency of beta-catenin mutations in borderline endometrioid tumours of the ovary. Oliva, E., Sarrió, D., Brachtel, E.F., Sánchez-Estévez, C., Soslow, R.A., Moreno-Bueno, G., Palacios, J. J. Pathol. (2006) [Pubmed]
  26. Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma. Albarracin, C.T., Jafri, J., Montag, A.G., Hart, J., Kuan, S.F. Hum. Pathol. (2000) [Pubmed]
  27. Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas. Khalifa, M.A., Mannel, R.S., Haraway, S.D., Walker, J., Min, K.W. Gynecol. Oncol. (1994) [Pubmed]
  28. Ezrin expression is related to poor prognosis in FIGO stage I endometrioid carcinomas. Köbel, M., Langhammer, T., Hüttelmaier, S., Schmitt, W.D., Kriese, K., Dittmer, J., Strauss, H.G., Thomssen, C., Hauptmann, S. Mod. Pathol. (2006) [Pubmed]
  29. Bcl-2 as a predictor of chemosensitivity and prognosis in primary epithelial ovarian cancer. Mano, Y., Kikuchi, Y., Yamamoto, K., Kita, T., Hirata, J., Tode, T., Ishii, K., Nagata, I. Eur. J. Cancer (1999) [Pubmed]
  30. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems. Young, R.H. Mod. Pathol. (2005) [Pubmed]
  31. Proliferating cell nuclear antigen in endometrial carcinoma: pretreatment identification of high-risk patients. Garzetti, G.G., Ciavattini, A., Goteri, G., De Nictolis, M., Romanini, C. Gynecol. Oncol. (1996) [Pubmed]
WikiGenes - Universities